Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium–glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551. (2nd September 2017) - Min, T.; Wali, L.; Williams, D.M.; Plummer, E.; Gurung, A.; Stephens, J.W.